Global menu

Our global pages

Close

Eversheds Sutherland Wierzbowski advised Icos Capital and EEC Magenta on next round investment in Reliability Solutions

  • Poland
  • Press_Releases

24-09-2020

Icos Capital announced the completion of a new round of equity investment into Reliability Solutions Sp. z o.o. (RS) with EEC Magenta as the other co-investor. In legal matters both funds were advised by team of VC lawyers of Eversheds Sutherland Poland consisting of Michał Karwacki (partner), Natalia Burchardt (senior associate), Kamil Ciodyk (lawyer) and Anna Wesołowska (lawyer). RS is a fast growth predictive & prescriptive analytics company delivering deep learning based Predictive and Prescriptive Analytics solutions for Industrial Operational Excellence to the industry. Icos Capital joined funding to help, inter alias, in the current expansion of RS technology into foreign markets.

RS helps to deal with a range of problems encountered in modern industry - predicting any kind of unwanted events, analizing different problem-solving scenarios, proposing the most cost-effective solutions and finally - optimizing the entire process. Such approach creates completely new opportunities and opens the door for Industry 4.0.

Icos Capital is a European wide early growth venture capital investor based out of Rotterdam. It is a collaborative venture capital firm working at the intersection of digital and sustainable industry. The Icos Capital Fund III (ICF III) plans to invest EUR 50 million in innovative scale-ups active in chemical, food and materials sectors. The fund has European corporations as anchor investors and strategic partners in Nouryon, Bühler Group and Royal Cosun. Funding also comes from Polish Public Limited Partner – PFR Ventures, which manages a fund of funds dedicated to CVC investments (PFR NCBR CVC supported by the National Centre for Research and Development).

This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

< Go back